Scrip
Avastin gets turned down for brain cancer in the EU
20 November 2009
Malini Guha
Roche's (Genentech) Avastin (bevacizumab) has been turned down for the treatment of relapsed glioblastoma (brain cancer) in the EU.
The negative decision from the EU's CHMP contrasts with the positive decision from the US FDA in May, which granted Avastin accelerated approval for use in previously...
Please Login to read the full article.
20 November 2009
Malini Guha
The negative decision from the EU's CHMP contrasts with the positive decision from the US FDA in May, which granted Avastin accelerated approval for use in previously...
Please Login to read the full article.
RELATED CONTENT
